• Overview
  • Eligibility
  • More info
  • Locations

A Comparison of the Ambu®AuraGain™ and the Laryngeal Mask Airway Supreme™ in Normal Airway Patients (NCT03108391)

The study is designed to compare the performance of the Ambu AuraGain Laryngeal Mask Airway and LMA Supreme in normal airway patients.
  • Device: Ambu AuraGain
    • Device: LMA Supreme
      Ages eligible for Study
      18 Years to 80 Years
      Genders eligible for Study
      All
      Accepts Healthy Volunteers
      No
      Inclusion Criteria:
      • American Society of Anesthesiologists Ⅰ-Ⅲ classification
      • Patients evaluated as eligible for a LMA
      • Body Mass Index ≤35kg/m2
      Exclusion Criteria:
      • Patients with known or predicted difficult airway
      • Active respiratory infection
      • Risk of aspiration
      • Head and neck surgery
      • Emergent surgery
      Ambu AuraGain Laryngeal Mask Airway is a newly designed supraglottic device. We design this study to test its clinical performance in normal airway patients, in comparison with LMA Supreme.

      1 locations

      China (1)
      • ChineseAMS
        recruiting
        Beijing, Beijing, China, 100144
      Status:
      recruiting
      Type:
      Interventional
      Phase:
      -
      Start:
      31 December, 2016
      Updated:
      10 April, 2017
      Participants:
      100
      Apply
      A girl giving information about available additional trials.

      FindMeCure helps you find, understand and join clinical trials from all over the world.

      There are more clinical trials for your condition!